Herbal Ingredients for Sleep Disease Management: Using Vitex Negundo, Chamomile An Comprehensive Review

Shivaji Patel, Paras yadav, Amaan, Shobha Sahu, Gyanesh Kumar Sahu,

doi:10.5281/zenodo.14982144

Review Paper | Open Access
Volume 02 | Issue 03 | Article Id IJSRT/250302106

Herbal Ingredients for Sleep Disease Management: Using Vitex Negundo, Chamomile An Comprehensive Review
Shivaji Patel* Paras yadav Amaan Shobha Sahu Gyanesh Kumar Sahu
Rungta Institute of Pharmaceutical sciences, Kohka, Kurud, Bhilai, Chhattisgarh, India

Abstract

Insomnia, a prevalent sleep disorder characterized by difficulty in initiating and maintaining sleep, adversely affects physical, mental, and emotional well-being. Conventional pharmacological treatments, although effective, are often associated with adverse effects, dependency, and tolerance. These limitations necessitate the development of safer, alternative therapeutic strategies. Nasal drug delivery systems have emerged as a promising approach due to their non-invasive nature, rapid onset of action, and direct access to the central nervous system, bypassing the hepatic first-pass metabolism. This study focuses on the of Vitex negundo and chamomile extracts, both renowned for their sedative and anxiolytic properties. Vitex negundo is rich in flavonoids and essential oils known for their sleep-inducing effects, while chamomile contains apigenin, a bioactive compound that binds to benzodiazepine receptors in the brain, promoting relaxation and sleep. The synergistic combination of these herbal extracts aims to provide a natural and effective solution for insomnia management without the risks associated with synthetic hypnotic. The results revealed optimal physicochemical characteristics suitable for nasal administration, ensuring sustained drug release and prolonged therapeutic effects. Pharmacological evaluations further demonstrated significant sedative activity, supporting the formulation's potential as an effective herbal remedy for insomnia.

Keywords

Insominia, Blood Brain Barrier,Nanotechnology, Vitex negundo,Chamomile

Introduction

Insomnia Disease

Insomnia is a common sleep disorder characterized by difficulty falling asleep, staying asleep, or waking up too early and not being able to return to sleep. It often leads to inadequate sleep, which can affect daily functioning, mood, and overall health.

Types of Insomnia

Acute Insomnia: Short-term, usually caused by stress, a significant life event, or environmental factors.
Chronic Insomnia: Lasts for a month or more, often associated with underlying health issues or persistent stress.
Comorbid Insomnia: Occurs alongside other conditions such as depression, anxiety, or chronic pain.
Onset Insomnia: Difficulty initiating sleep.
Maintenance Insomnia: Difficulty staying asleep throughout the night.

Causes

Lifestyle Factors: Irregular sleep schedules, excessive caffeine or alcohol intake, lack of physical activity.
Medical Conditions: Chronic pain, asthma, acid reflux, neurological disorders, or hormonal changes (e.g., menopause).
Psychological Conditions: Stress, anxiety, depression.
Medications: Certain drugs for hypertension, asthma, or depression.
Environmental Factors: Noise, light, uncomfortable bedding, or temperature.

Symptoms

Difficulty falling asleep or staying asleep.
Waking up frequently during the night.
Feeling tired or fatigued despite sufficient time in bed.
Mood disturbances, irritability, or anxiety.
Reduced concentration and memory problems.
Decreased performance at work or school.

Pathophysiology

The pathophysiology of insomnia involves multiple complex interactions between the brain's sleep-wake regulatory mechanisms, psychological factors, and environmental influences. Insomnia can arise from hyperarousal, dysregulation of circadian rhythms, and disruptions in the neurotransmitters and hormones that control sleep.

Pathophysiological Mechanisms:

Hyperarousal:

- Insomnia is often associated with an increased state of physiological and psychological arousal, even at night.
- Hyperarousal may involve increased brain metabolic activity, elevated levels of stress hormones (e.g., cortisol), and sympathetic nervous system activation.

Neurotransmitter Imbalance

- Sleep is regulated by a balance between sleep-promoting and wake-promoting neurotransmitters.
  - Wake-promoting neurotransmitters: Dopamine, norepinephrine, serotonin, and orexin.
  - Sleep-promoting neurotransmitters: GABA (gamma-aminobutyric acid), adenosine.

Insomnia, a prevalent sleep disorder, is often caused by an imbalance in neurotransmitters that regulate the sleep-wake cycle. These chemical messengers in the brain play a crucial role in maintaining proper sleep patterns by either promoting wakefulness or inducing sleep. One of the primary neurotransmitters involved is Gamma-Aminobutyric Acid (GABA), the brain's main inhibitory neurotransmitter that helps calm neural activity. A deficiency in GABA can lead to heightened brain activity, resulting in difficulty falling or staying asleep. Another key neurotransmitter is Serotonin, which influences mood and sleep onset. Serotonin also serves as a precursor to Melatonin, the hormone responsible for regulating the circadian rhythm. Low levels of serotonin can impair melatonin production, disrupting the sleep-wake cycle and contributing to insomnia.Additionally, Dopamine, a neurotransmitter associated with wakefulness and arousal, when present in high levels at night, can cause restlessness and sleep disturbances. Norepinephrine, which plays a role in the body’s stress response and alertness, can lead to hyperarousal if overactive, making it hard to stay asleep. Orexin (Hypocretin) is another neurotransmitter that promotes wakefulness; its increased activity has been linked to insomnia as it keeps the brain alert. Lastly, Glutamate, the main excitatory neurotransmitter, when excessively active, results in heightened brain activity, making relaxation and sleep initiation difficult.

The pathological mechanisms of insomnia: